Vimarsana
Biggest News Aggregation in the World

Page 47 - Eu Press News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eu Press. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eu Press Today - Breaking & Trending Today

Proposals of QPR Software Plc's Shareholders' Nomination Committee to the Annual General Meeting 2023 - Vimarsana News

Proposals of QPR Software Plc's Shareholders' Nomination Committee to the Annual General Meeting 2023

QPR SOFTWARE PLC                STOCK EXCHANGE RELEASE... | January 11, 2023

Rovio Entertainment Corp.: Proposals of the Shareholders' Nomination Board on the composition and remuneration of the Board of Directors of Rovio Entertainment Corporation - Vimarsana News

Rovio Entertainment Corp.: Proposals of the Shareholders' Nomination Board on the composition and remuneration of the Board of Directors of Rovio Entertainment Corporation

Rovio Entertainment Corporation           Stock Exchange Release          January 9, 2023 at 6.00 p.m. EET Proposals of the... | January 9, 2023

Baltman OÜ and Kalaport OÜ reached compromise agreement in a court dispute - Vimarsana News

Baltman OÜ and Kalaport OÜ reached compromise agreement in a court dispute

Baltman OÜ, a subsidiary of AS Baltika, and Kalaport OÜ entered into a compromise on January 5, 2023, which ended the legal dispute regarding the lease agreement for the Ivo Nikkolo store... | January 6, 2023

Schouw & Co. share buy-back programme, week 50 2022 - Vimarsana News

Schouw & Co. share buy-back programme, week 50 2022

On 27 December 2021, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 10 of 21 December 2021. Under the programme, Schouw & Co. will acquire shares for... | December 19, 2022

Tiziana Life Sciences Announces Completion of Prerequisite Pre-Clinical Safety Study - Vimarsana News

Tiziana Life Sciences Announces Completion of Prerequisite Pre-Clinical Safety Study

NEW YORK, Dec. 15, 2022 -- Tiziana Life Sciences Ltd.  , a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announces... | December 15, 2022